IMMUNESTRATIFY

IMMUNESTRATIFY The molecular immune signature in ME/CFS as stratification tool for future personalized treatment

Background

About the study

ME/CFS is a disease where people can have very different symptoms, suggesting that there might be multiple subtypes of the disease. The researchers will answer two main questions:

  1. Can patients with ME/CFS be classified into subgroups based on immune signatures? The researchers will investigate whether classification using previously identified immune signatures that occur in patients with other disease states (who also experience severe fatigue) can be done. And can specific symptoms be linked to these immune signatures?
  2. Are immune cells of ME/CFS patients hypersensitive to stimuli and does this result in pathogenic inflammatory substances?

For this project blood samples from the people with ME/CFS from the NMCB will be studied. This project aims to improve our understanding on the role of the immune system in ME/CFS and provide clues for the development of new treatments. The immune signatures detected in ME/CFS patients will be made available as a diagnostic test.

Subproject

Team

Bart Humer

Bart Humer

PhD Student

Wim Dik

Dr. Wim Dik

Laboratory specialist in medical immunology

Dr. Marjan Versnel

Principal investigator